TETRA Technologies, Inc. TTI
Set alert
At close · Oct 30
After hours · Oct 30, 4:01 PM ET
- YTD
- -37.46%
- 1 year
- -16.41%
- Open
- 5.90
- Prev close
- 5.97
- Mkt cap
- 867.71M
- Vol
- 2.37M
- Avg vol
- 2.12M
- EPS
- 0.05
- P/E
- 117.20
- Div yield
- 0.00%
More statistics
- Low
- 5.73
- High
- 5.91
- Forward P/E
- 23.07
- Beta
- 1.24
- Short ratio
- 5.44
- Inst. own
- 94.84%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 27, 2026
- 50-d avg
- 8.14
- 200-d avg
- 9.29
- 1y target
- 11.88
News
1 week ago newsfilecorp.com
Thiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis
Investigator-initiated study led by Dr. Larry Greenbaum of Emory University to evaluate once-daily oral powder TTI-0102, designed to improve adherence San Diego, California--(Newsfile Corp. - October…
-
3 weeks ago benzinga.com
Clear Street Upgrades Tetra Technologies to Buy, Announces $11 Price Target
Clear Street analyst Tim Moore upgrades Tetra Technologies (NYSE:TTI) from Hold to Buy and announces $11 price target.
1 month ago prnewswire.com
TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR THIRD QUARTER 2026 EARNINGS CONFERENCE CALL
SPRING, Texas, Sept. 30, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE: TTI) will release Third Quarter 2026 results after the market closes on November 2, 2026 and will host a conference call…
-
1 month ago benzinga.com
Stifel Maintains Buy on Tetra Technologies, Lowers Price Target to $12
Stifel analyst Stephen Gengaro maintains Tetra Technologies (NYSE:TTI) with a Buy and lowers the price target from $13 to $12.
1 month ago defenseworld.net
Financial Review: Valaris (NYSE:VAL) vs. Tetra Technologies (NYSE:TTI)
Valaris (NYSE: VAL - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Report) are both energy companies, but which is the superior business? We will contrast the two businesses based on…
1 month ago defenseworld.net
Tetra Technologies (NYSE:TTI) vs. MIND Technology (NASDAQ:MIND) Critical Analysis
MIND Technology (NASDAQ: MIND - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Report) are both small-cap energy companies, but which is the superior stock? We will contrast the two…
1 month ago newsfilecorp.com
Thiogenesis Reports Results of 2026 Annual and Special Meeting of Shareholders and Provides Corporate Update
San Diego, California--(Newsfile Corp. - September 21, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQB: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biopharmaceutical company…
1 month ago seekingalpha.com
Tetra Technologies Potential Growth Story Boosted By External Trends
Tetra Technologies is an interesting investment opportunity, given the sizable share price pullback and its potential for growth in the next few years. TTI's innovations and services are poised for…
1 month ago benzinga.com
12 Energy Stocks Moving In Thursday's After-Market Session
Gainers TMD Energy (AMEX:TMDE) stock increased by 3.6% to $0.72 during Thursday's after-market session. The company's market cap stands at $16.9 million. KNOT Offshore Partners (NYSE:KNOP) stock…
1 month ago newsfilecorp.com
Thiogenesis Engages Brisco Capital for Investor Relations
San Diego, California--(Newsfile Corp. - September 3, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQB: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company…
1 month ago prnewswire.com
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
SPRING, Texas, Sept. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, Treasurer and VP…
2 months ago defenseworld.net
Technip Energies (OTCMKTS:THNPY) versus Tetra Technologies (NYSE:TTI) Critical Contrast
Technip Energies (OTCMKTS:THNPY - Get Free Report) and Tetra Technologies (NYSE: TTI - Get Free Report) are both energy companies, but which is the superior business? We will compare the two…
2 months ago seekingalpha.com
Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript
Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript
2 months ago marketbeat.com
Tetra Technologies Q2 Earnings Call Highlights
Tetra Technologies NYSE: TTI reported second-quarter revenue of $185.7 million, up 19% sequentially and 7% from the prior-year period, as strength in international and offshore operations offset…
2 months ago zacks.com
Tetra Technologies (TTI) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with…
2 months ago seekingalpha.com
TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript
TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript
2 months ago zacks.com
Tetra Technologies (TTI) Q2 Earnings Meet Estimates
Tetra Technologies (TTI) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago.
2 months ago zacks.com
Compared to Estimates, Tetra Technologies (TTI) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Tetra Technologies (TTI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with…
2 months ago prnewswire.com
TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
SPRING, Texas, Aug. 3, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three and six months ended June 30, 2026. Second-Quarter…
3 months ago globenewswire.com
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
STAT3 acts as a convergent node downstream of multiple signaling pathways implicated in ulcerative colitis (UC), integrating immune dysregulation, inflammation and tissue remodeling
3 months ago zacks.com
Tetra Technologies (TTI) to Report Q2 Results: What to Know Ahead of the Release
Tetra Technologies (TTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 months ago prnewswire.com
TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS CONFERENCE CALL
SPRING, Texas, July 13, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE:TTI) will release Second Quarter 2026 results after the market closes on August 3, 2026 and will host a conference call to…
3 months ago newsfilecorp.com
Thiogenesis Receives FDA Rare Pediatric Disease Designation for TTI-0102 for the Treatment of Leigh Syndrome
San Diego, California--(Newsfile Corp. - July 13, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company…
-
4 months ago benzinga.com
Northland Capital Markets Maintains Outperform on Tetra Technologies, Raises Price Target to $14
Northland Capital Markets analyst Bobby Brooks maintains Tetra Technologies (NYSE:TTI) with a Outperform and raises the price target from $11.5 to $14.
-
4 months ago benzinga.com
TETRA Technologies Introduces TETRA Neptune Z-Lite, High-Density Completion Fluid Designed For Deepwater And High-Pressure Well Applications
Using Neptune Chemistry to Achieve Required Density With Lower Zinc Content; Awarded Three-Well 20k psi Deepwater Project in the Gulf of America With Estimated Start in 2026SPRING, Texas, June 29,…
5 months ago benzinga.com
Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100M stock offering. XOS, Wellchange, and J-Star are top gainers while Jianzhi, NRx, and Volato are…
-
5 months ago benzinga.com
TETRA Technologies Prices $100M Public Stock Offering Of 10.81M Shares At $9.25/Share, To Use Stock Offering Proceeds for Arkansas Bromine Project
TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced the pricing of an underwritten public offering of 10,810,811 shares of its common stock, par value $0.01 per share…
-
5 months ago benzinga.com
Tetra Technologies Commences $100M Underwritten Public Offering Of Its Common Stock
TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced the commencement of an underwritten public offering of $100 million of shares of its common stock, par value $0.01 per…
-
5 months ago benzinga.com
Tetra Technologies Says Arkansas Bromine Production Facility Expected To Be Operational By End Of 2027
Phase 1 of the Evergreen Project, which included site preparation, power infrastructure, and installation of the bromine tower, was completed in December 2025. Phase 2, which encompasses the major…
-
5 months ago benzinga.com
Tetra Technologies' Board Approves Final Investment Decision For The Development Of The Company's Bromine Production Facility Near Stamps, Arkansas; The Vertically Integrated Production Case Is Expected To Generate A Bromine Business NPV Of $607M; The Facility Is Expected To Commence First Production In Early 2028
"The Board's approval of the final investment decision for our Arkansas bromine facility marks a major milestone in TETRA's forty-five-year history," said Brady Murphy, President and Chief Executive…
6 months ago benzinga.com
Tetra Technologies Q1 2026 Earnings Call: Complete Transcript
Tetra Technologies Q1 2026 Earnings Call: Complete Transcript
6 months ago benzinga.com
Earnings Scheduled For April 29, 2026
Earnings Scheduled For April 29, 2026
8 months ago benzinga.com
Earnings Scheduled For February 25, 2026
Earnings Scheduled For February 25, 2026
9 months ago benzinga.com
This Darden Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
This Darden Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
1 year ago benzinga.com
Earnings Scheduled For October 28, 2025
Earnings Scheduled For October 28, 2025
1 year ago benzinga.com
Top 2 Energy Stocks That May Fall Off A Cliff This Quarter
Top 2 Energy Stocks That May Fall Off A Cliff This Quarter
-
1 year ago benzinga.com
Earnings Scheduled For February 25, 2025
Earnings Scheduled For February 25, 2025
-
2 years ago benzinga.com
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
-
2 years ago benzinga.com
Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday
U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday.
-
3 years ago benzinga.com
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for…
-
3 years ago benzinga.com
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
-
3 years ago benzinga.com
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
-
3 years ago benzinga.com
Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Gainers American Superconductor Corporation (NASDAQ: AMSC) shares surged 112.1% to $21.38 in pre-market trading. AMSC is expected to report first-quarter results on Aug. 9, 2023.
-
3 years ago benzinga.com
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
-
3 years ago benzinga.com
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 469 companies hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 337 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 479 stocks made new 52-week lows.